SESSION 5 - Locally advanced NSCLC
Combined modality treatment for NSCLC with N2 disease
Date
12 Mar 2021Session
SESSION 5 - Locally advanced NSCLCPresenters
C. Chan, UKResources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Treatment of locally advanced NSCLC in the elderly
Presenter: D. Woolf, UK
Session: SESSION 5 - Locally advanced NSCLC
Resources:
Slides
Webcast
Role of surgery for N2 disease
Presenter: P. E. van Schil, BE
Session: SESSION 5 - Locally advanced NSCLC
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Treatment selection on NSCLC with Met Exon14 skipping mutation
Presenter: M. Herrera Juarez, ES
Session: SESSION 5 - Locally advanced NSCLC
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Immunotherapy in EGFR-mutant NSCLC:Just a dream or maybe not?
Presenter: E. Lai, IT
Session: SESSION 5 - Locally advanced NSCLC
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Squamous cell carcinoma of the lung: Chemotherapy as a weapon to achieve resectability
Presenter: A. Miranda Pires, PT
Session: SESSION 5 - Locally advanced NSCLC
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.